2021 ASH Annual Meeting: Focus on GVHD for Pharmacists
Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care ...
Updated results from a real-world analysis confirm that ruxolitinib is an effective treatment option for patients with ...
Prophylactic treatment with subcutaneous fitusiran administered once-monthly reduced bleeding risk in patients with ...
According to a poster presented at the 2021 ASH Annual Meeting by Maria Queralt Salas, MD, from the Hospital Clinic of ...
The combination of daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell ...
Prescribing chemotherapy is not a universal practice of advanced practice providers (APPs) in the oncology community, ...
Advertisement
Advertisement
